Avalo Therapeutics (AVTX) Short Interest
Nasdaq • AVTX • US05338F3064
As of Oct 21, 2026, ORTEX estimated 28.2% of free float sold short, 9.1 days to cover, cost to borrow 0.54%. Sign up for live short interest data.
Nasdaq • AVTX • US05338F3064
As of Oct 21, 2026, ORTEX estimated 28.2% of free float sold short, 9.1 days to cover, cost to borrow 0.54%. Sign up for live short interest data.
This page tracks how heavily Avalo Therapeutics (Nasdaq:AVTX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Avalo Therapeutics (Nasdaq: AVTX) has a market capitalization of $379.16M. Last close $7.07 (as of 2026-11-05); 52-week range $6.53 to $24.27. ORTEX data as of 2026-10-21: short interest was 28.16% of free float, 9.1 days to cover and the average cost to borrow was 0.54%. Sign up for live short interest data.